Monday 16 November 2026
Export KYNB’s income statement to Excel — free account
Kyntra Bio Inc
KYNBKyntra Bio Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.4 million, down 78.3% from fiscal 2024.
- Revenue
- n/m
- EPS
- n/m
- Free cash flow
- n/m
Quarter to June 2026, against a year earlier
3.44
0.15
−4.18%
Follow KYNB
Alert me
What it owns vs. what it owes End of fiscal 2025, 31 December 2025
Debt has fallen from $97.4M to $71.9M since FY16. Liabilities are $17.0M more than assets: shareholders’ equity is negative. What is a balance sheet?
Owns
$361.0KLong-term assets
$10.1MOther short-term assets
$109.1MCash & all investments
Funded by
$136.6MOther liabilities
Debt is 0.0% of the total; liabilities are $17.0M more than assets.
Net cash fell from 48% of assets to 32% since FY16.
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | $0.5B | $0.9B | $0.9B | $0.9B | $0.8B | $0.8B | $0.6B | $0.4B |
| Net debt (debt less cash) | −$0.2B | −$0.6B | −$0.6B | −$0.6B | −$0.7B | −$0.5B | −$0.3B | −$0.1B |
| Net debt ÷ assets (right axis) | −48.3% | −72.2% | −64.6% | −65.0% | −80.3% | −60.8% | −54.9% | −32.3% |
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
253.18 | 735.72 | 621.40 | 533.76 | 686.54 | 405.19 | 422.01 | 203.45 | 50.48 | 88.98 |
Receivables |
10.45 | 8.45 | 63.68 | 28.46 | 41.88 | 17.40 | 16.30 | 5.12 | 0.48 | 0.22 |
Inventory |
— | — | — | 6.89 | 16.53 | 31.02 | 40.44 | 17.17 | 3.16 | 3.74 |
Other current assets |
2.89 | 4.80 | 4.93 | 8.18 | 10.16 | 12.45 | 14.08 | 65.78 | 110.85 | — |
Total current assets |
266.52 | 748.97 | 690.02 | 702.49 | 755.11 | 474.06 | 492.83 | 331.56 | 196.51 | 99.07 |
Property, Plant, Equpment (Net) |
123.66 | 129.48 | 127.20 | 42.74 | 33.65 | 28.28 | 20.61 | 4.79 | — | — |
Long-Term Investments |
71.01 | 10.51 | 55.82 | 61.12 | 2.97 | 171.62 | 9.41 | 5.29 | — | 20.16 |
Long-term assets (Other) |
8.37 | 9.70 | 7.57 | 11.44 | 3.46 | 8.75 | 7.35 | 22.25 | 18.02 | 0.36 |
Total non-current assets |
203.04 | 149.68 | 190.58 | 154.91 | 71.73 | 299.76 | 117.26 | 91.97 | 18.02 | 20.52 |
Total Assets |
469.55 | 898.65 | 880.60 | 857.40 | 826.84 | 773.82 | 610.09 | 423.53 | 214.53 | 119.59 |
Accounts Payable |
6.22 | 5.51 | 9.14 | 6.09 | 24.79 | 26.10 | 30.76 | 15.78 | 5.06 | 3.75 |
Accrued Expenses |
50.91 | 63.78 | 66.12 | 83.82 | 118.33 | 172.60 | 219.77 | 132.99 | 62.04 | 20.18 |
Current Part of Capital Lease |
— | — | — | 12.35 | 12.33 | 0.01 | — | — | — | — |
Current Revenue (Deferred) |
7.99 | 16.67 | 13.77 | 0.49 | 6.55 | 15.86 | 12.74 | 12.74 | 27.29 | 5.31 |
Other current liabilities |
58.90 | 80.45 | 79.89 | 83.32 | 124.88 | 188.45 | 232.48 | 43.52 | 38.92 | — |
Total current liabilities |
65.13 | 85.96 | 89.03 | 102.75 | 163.19 | 225.50 | 273.56 | 217.67 | 133.31 | 29.24 |
Long Term Debt (Total) |
97.35 | 97.76 | 107.96 | 37.61 | 25.39 | 106.39 | 96.65 | 71.93 | 73.09 | — |
Non-current Revenue (Deferred) |
110.92 | 141.90 | 139.15 | 99.45 | 138.47 | 186.80 | 185.72 | 157.56 | 114.71 | 0.26 |
Minority Interests |
— | — | — | — | — | — | — | 21.48 | 21.48 | 21.48 |
Non-current Liabilities (Other) |
21.05 | 25.29 | 26.79 | 82.19 | 57.49 | 43.63 | 72.69 | 73.54 | 77.05 | 85.62 |
Total non-current liabilities |
229.32 | 264.95 | 263.10 | 219.25 | 222.20 | 319.21 | 338.01 | 389.54 | 286.33 | 107.36 |
Total liabilities |
294.44 | 350.91 | 352.13 | 321.99 | 385.39 | 544.71 | 611.57 | 607.21 | 419.64 | 136.60 |
Additional Paid In Capital |
625.90 | 1,160.09 | 1,226.45 | 1,300.73 | 1,399.77 | 1,476.41 | 1,541.02 | 1,643.64 | 1,668.62 | 1,677.18 |
Common Stock (Net) |
0.64 | 0.83 | 0.85 | 0.88 | 0.91 | 0.93 | 0.94 | 0.99 | 1.01 | 1.01 |
Retained Earnings |
(469.74) | (630.66) | (715.83) | (784.72) | (974.01) | (1,264.03) | (1,557.69) | (1,841.92) | (1,889.50) | (1,706.05) |
Common Equity (Total) |
175.11 | 547.74 | 528.47 | 535.41 | 441.45 | 229.11 | (1.48) | (183.68) | (205.11) | (17.01) |
Shareholders Equity (Total) |
175.11 | 547.74 | 528.47 | 535.41 | 441.45 | 229.11 | (1.48) | (183.68) | (205.11) | (17.00) |
Shareholders Equity and Liabilities (Total) |
469.55 | 898.65 | 880.60 | 857.40 | 826.84 | 773.82 | 610.09 | 423.53 | 214.53 | 119.59 |
Shares (Common) |
2.55 | 3.30 | 3.42 | 3.51 | 3.66 | 3.72 | 3.77 | 3.95 | 4.04 | 4.05 |
Shareholders Equity (Tangible) |
175.11 | 547.74 | 528.47 | 535.41 | 441.45 | 229.11 | (1.48) | (183.68) | (205.11) | (17.00) |
Net Debt |
(155.83) | (637.95) | (513.45) | (496.15) | (661.15) | (298.80) | (325.36) | (131.52) | 22.61 | (88.98) |
Total Debt |
97.35 | 97.76 | 107.96 | 37.61 | 25.39 | 106.39 | 96.65 | 71.93 | 73.09 | — |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 25 Oct 2026